Literature DB >> 17235694

Chelating compound, chrysoidine, is more effective in both antiprion activity and brain endothelial permeability than quinacrine.

Katsumi Doh-ura1, Kazuhiko Tamura, Yoshiharu Karube, Mikihiko Naito, Takashi Tsuruo, Yasufumi Kataoka.   

Abstract

1. As an extension of our previous study of quinacrine and its derivatives, chelating chemicals were screened to obtain more effective, better brain-permeable antiprion compounds using either prion-infected neuroblastoma cells or brain capillary endothelial cells.2. Eleven chemicals were found to have antiprion activity. Most of them shared a common structure consisting of benzene or naphthalene at either end of an azo bond. Structure-activity data suggest that chelating activity is not necessary but might contribute to the antiprion action.3. Chrysoidine, a representative compound found here, was about 27 times more effective in the antiprion activity and five times more efficiently permeable through the brain capillary endothelial cells than quinacrine was.4. These chemicals might be useful as compounds for development of therapeutics for prion diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17235694     DOI: 10.1007/s10571-006-9122-0

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  18 in total

1.  Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels.

Authors:  A Frostell-Karlsson; A Remaeus; H Roos; K Andersson; P Borg; M Hämäläinen; R Karlsson
Journal:  J Med Chem       Date:  2000-05-18       Impact factor: 7.446

2.  Drug transfer across the blood-brain barrier: correlation between in vitro and in vivo models.

Authors:  M P Dehouck; P Jolliet-Riant; F Brée; J C Fruchart; R Cecchelli; J P Tillement
Journal:  J Neurochem       Date:  1992-05       Impact factor: 5.372

3.  Surface plasmon resonance analysis for the screening of anti-prion compounds.

Authors:  Satoshi Kawatake; Yuki Nishimura; Suehiro Sakaguchi; Toru Iwaki; Katsumi Doh-ura
Journal:  Biol Pharm Bull       Date:  2006-05       Impact factor: 2.233

Review 4.  Metallic prions.

Authors:  David R Brown
Journal:  Biochem Soc Symp       Date:  2004

5.  Does the use of stained maggots present a risk of bladder cancer to coarse fishermen?

Authors:  R A Cartwright; M R Robinson; R W Glashan; B K Gray; P Hamilton-Stewart; S C Cartwright; D Barham-Hall
Journal:  Carcinogenesis       Date:  1983       Impact factor: 4.944

6.  Quinoline derivatives are therapeutic candidates for transmissible spongiform encephalopathies.

Authors:  Ikuko Murakami-Kubo; Katsumi Doh-Ura; Kensuke Ishikawa; Satoshi Kawatake; Kensuke Sasaki; Jun-Ichi Kira; Shigeru Ohta; Toru Iwaki
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

7.  Uptake and efflux of quinacrine, a candidate for the treatment of prion diseases, at the blood-brain barrier.

Authors:  Shinya Dohgu; Atsushi Yamauchi; Fuyuko Takata; Yasufumi Sawada; Shun Higuchi; Mikihiko Naito; Takashi Tsuruo; Susumu Shirabe; Masami Niwa; Shigeru Katamine; Yasufumi Kataoka
Journal:  Cell Mol Neurobiol       Date:  2004-04       Impact factor: 5.046

8.  Analyses of frequency of infection, specific infectivity, and prion protein biosynthesis in scrapie-infected neuroblastoma cell clones.

Authors:  R E Race; B Caughey; K Graham; D Ernst; B Chesebro
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

9.  Amyloid imaging probes are useful for detection of prion plaques and treatment of transmissible spongiform encephalopathies.

Authors:  Kensuke Ishikawa; Katsumi Doh-Ura; Yukitsuka Kudo; Noriyuki Nishida; Ikuko Murakami-Kubo; Yukio Ando; Tohru Sawada; Toru Iwaki
Journal:  J Gen Virol       Date:  2004-06       Impact factor: 3.891

10.  Coarse fishing and urothelial cancer: a regional case-control study.

Authors:  T Sorahan; G Sole
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

View more
  6 in total

1.  Prediction of antiprion activity of therapeutic agents with structure-activity models.

Authors:  Katja Venko; Špela Župerl; Marjana Novič
Journal:  Mol Divers       Date:  2013-09-20       Impact factor: 2.943

2.  Quinacrine promotes replication and conformational mutation of chronic wasting disease prions.

Authors:  Jifeng Bian; Hae-Eun Kang; Glenn C Telling
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-07       Impact factor: 11.205

3.  Prophylactic effect of dietary seaweed Fucoidan against enteral prion infection.

Authors:  Katsumi Doh-Ura; Tomoko Kuge; Miyuki Uomoto; Keiko Nishizawa; Yuri Kawasaki; Masahiko Iha
Journal:  Antimicrob Agents Chemother       Date:  2007-04-16       Impact factor: 5.191

Review 4.  Recent advances in prion chemotherapeutics.

Authors:  Valerie L Sim; Byron Caughey
Journal:  Infect Disord Drug Targets       Date:  2009-02

5.  Extraction of Illegal Dyes from Red Chili Peppers with Cholinium-Based Deep Eutectic Solvents.

Authors:  Shuqiang Zhu; Dongling Liu; Xinyue Zhu; Along Su; Haixia Zhang
Journal:  J Anal Methods Chem       Date:  2017-07-31       Impact factor: 2.193

6.  Development of a highly sensitive and specific immunoassay for determining chrysoidine, a banned dye, in soybean milk film.

Authors:  Hongtao Lei; Jin Liu; Lijun Song; Yudong Shen; Simon A Haughey; Haoxian Guo; Jinyi Yang; Zhenlin Xu; Yueming Jiang; Yuanming Sun
Journal:  Molecules       Date:  2011-08-17       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.